Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Esophageal Neoplasms × Immunotherapy × Clear all

Phase

Status

Recruiting 7 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Lung Diseases 1 Locally Advanced Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Radiotherapy 3 Paclitaxel 3 Fluorouracil 3 nimotuzumab 2 Taxes 2 S 1 (combination) 2 Radiation 2 Oxaliplatin 2 Nivolumab 2 Ferrosoferric Oxide 2 Cisplatin 2 Cetuximab 2 Carboplatin 2 pembrolizumab 1 entinostat 1 apatinib 1 Watchful Waiting 1 Trastuzumab 1 TH 302 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Polymerase Chain Reaction 1 Observation 1 Nimodipine 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Immunotherapy 1 Gene Expression Profiling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05245760 2022-11-08

CRATER

University of Kentucky

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡